Novo Nordisk filed for FDA approval in December 2025
Additionally, a 5 mol/L elevation in plasma Hcy was associated with a 1.61.8 times increased relative risk of coronary heart disease [47]
Those most at risk include vegans and vegetarians, people with digestive conditions such as Crohn's disease, coeliac disease or IBS, those taking long-term metformin or proton pump inhibitors, older adults whose ability to absorb B12 through the gut declines naturally with age, those with pernicious anaemia, and anyone with a history of chronic alcohol use
A new large-scale study from Truveta and collaborators from Providence, Johns Hopkins, Duke University, and more suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs)semaglutide and tirzepatidemay have another powerful benefit: reducing alcohol-related hospitalizations in people with alcohol use disorder (AUD)
Weight Loss Injections: Your Path to Lasting Results Weight loss can be challenging, especially when traditional diets and exercises dont seem to work
Acknowledgements The authors would like to thank Mrs
